Pure Bioscience, Inc.
PURE- Exchange
- OTC
- Industry
- Miscellaneous Chemical Products
- SEC CIK
- 0001006028
No open-market purchases or sales by Pure Bioscience, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PURE, Q2 2026
No superinvestor reported holding PURE at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Pure Bioscience, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2023 (view filing)5:55 PM ET | Mar 21 | 1 day | Blotner BernardDirector | PPurchase | +10.0K | $0.1299 | +$1.30K | New position10.0K after | |
| Mar 22, 2023 (view filing)5:53 PM ET | Mar 22 | Same day | Bartlett Robert FCEO | PPurchase | +50.0K | $0.155 | +$7.75K | New position50.0K after | |
| Dec 19, 2022 (view filing)6:48 PM ET | Dec 15 | 4 days | Lee Tom YChief Executive Officer | PPurchase | +50.0K | $0.131 | +$6.55K | +1.0%5.00M after | |
| Mar 22, 2022 (view filing)9:49 PM ET | Mar 16-21 | 6 daysLate | Lee Tom YChief Executive Officer | PPurchase | +219.5K | $0.1951 | +$42.8K | +4.6%4.95M after | 3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Pure Bioscience, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding PURE in 13F filings for Q2 2026.